James D Brenton

59PUBLICATIONS
640CO-AUTHORS
Haematological tumoursCancer geneticsPredictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Sep 28, 2026
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment.

|Apr 13, 2026
Rethinking ovarian cancer III: the past decade and future directions.

Frances R Balkwill, Céline M Laumont, Nikki Burdett

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Feb 03, 2026
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.

Estela González-Gualda, Marika A V Reinius, David Macias

|Dec 10, 2025
Somatic evolution following cancer treatment in normal tissue.

Oriol Pich, Sophia Ward, Andrew Rowan

|Nov 20, 2025
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

Daniel R Barnes, Jonathan P Tyrer, Joe Dennis

Pageof 10

Frequent Collaborators

19 joint publications

Iain McNeish

18 joint publications

Paul Pharoah

16 joint publications

Anna DeFazio

14 joint publications

Susan Ramus